Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Victhom Human Bionics Inc V.VHB

TSXV:VHB - Post Discussion

Victhom Human Bionics Inc > VICTHOM TO LIST ON TSX VENTURE EXCHANGE AND VOLUNT
View:
Post by mbanx on Dec 30, 2009 2:30pm

VICTHOM TO LIST ON TSX VENTURE EXCHANGE AND VOLUNT

Victhom Human Bionics Inc., concurrent to its voluntary delisting from the Toronto Stock Exchange, has confirmed that the common shares of the company will commence trading on the TSX Venture Exchange, effective at the opening of trading on Dec. 31, 2009. It will be classified as a Tier 1 technology issuer on the TSX-V. Victhom's common shares trading symbol, "VHB", and its CUSIP number, 92581Q502, will remain unchanged.

It is Victhom's view that a listing on the TSX-V is appropriate, given the current nature of its activities, and is consistent with the continuing process of cost rationalization.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities